Remove 2030 Remove Pharmaceutical Companies Remove Vaccines
article thumbnail

PharmaLytica 2024: charting India’s pharma’s path to USD 130 billion by 2030 from the powerhouse hub of Hyderabad

Express Pharma

PharmaLytica 2024 offered a unique platform for stakeholders to engage in discussions covering the full spectrum of pharma machinery and packaging, lab analytical and cleanroom solutions, and pharmaceutical ingredients. Indian pharmaceutical companies are ramping up R&D investments for novel drug discoveries.

Packaging 105
article thumbnail

India’s opportunity to lead the future of healthcare delivery drives through sustainable pharma cold chain and storage

Express Pharma

The healthcare and pharma sector, standing on the frontlines, witnessed the most upheaval and evolution, especially in vaccine development, cold chain, storage and last-mile delivery. Refrigeration systems today are indispensable for the pharmaceutical cold chain and storage.

Vaccines 105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

MODIFI unveils growth – boosting solutions for pharma SMEs at IPC, backs ‘Make in India’ drive

Express Pharma

With a well-established infrastructure and robust capabilities in drug manufacturing, India supplies over 50 per cent of global demand for various vaccines and is a major exporter of generic medicines.

article thumbnail

Greening India’s industrial horizon: Navigating climate resilience in pharma and beyond

Express Pharma

India’s pharmaceutical industry is a global powerhouse. It is already a massive $50 billion market and is projected to grow to $130 billion by 2030. India makes 60 per cent of the world’s vaccines and 20 per cent of the world’s generic drugs. who have sustainability ambitions will also pressure the sector to go green.

article thumbnail

Could virtual reality become an essential tool for healthcare education?

pharmaphorum

Practical examples of this include healthcare professionals using VR to learn various medical procedures or for the technology to be used to teach broader society about public health issues, such as the importance of vaccination. When both ‘treatments’ were combined, the vaccination intention increased even further. The more you know.

Vaccines 145
article thumbnail

Pharma sector awaits Budget 2024 for innovation boost and regulatory reforms

Express Pharma

The government’s initiative to implement a draft strategy aimed at promoting innovation, R&D, and industry-led innovation growth in India’s MedTech and Pharmaceutical industries is a welcome move. This would stimulate new investments in both R&D and production initiatives.

article thumbnail

Nine for 2023, part three: thriving or surviving?

pharmaphorum

In this final instalment of IQVIA EMEA Thought Leadership’s Nine for 2023 three-part series, focusing on issues that will change the direction of healthcare and the pharmaceutical industry this year, three key competitive issues for pharmaceutical companies in 2023 are assessed.